Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1749 of 6351
-
New hope for Hard-to-Treat leukemia? early trial launches
Disease control Recruiting nowThis is a clinical study aiming to assess pharmacokinetics, pharmacodynamics and preliminary efficacy of ZE46-0134 in patients with FLT3 and spliceosome mutated Relapsed or Refractory Acute Myeloid Leukemia
Phase 1 • Sponsor: Lomond Therapeutics Holdings, Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
New liquid embolic agent could shrink dangerous brain malformations
Disease control Recruiting nowThis study is designed as a prospective, multi-center, open-label, non-inferiority, randomized controlled clinical trial. The control device is Onyx Liquid Embolic System marketed by Micro Therapeutics Inc. DBA ev3 Neurovascular (NMPA (J) 20173136690). According to the inclusion …
Sponsor: MicroPort NeuroTech Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC
-
New depression pill shows promise in Mid-Stage trial
Symptom relief CompletedThe purpose of this study is to determine the efficacy and safety of BHV-7000 in participants with Major Depressive Disorder (MDD)
Phase 2 • Sponsor: Biohaven Therapeutics Ltd. • Aim: Symptom relief
Last updated Jun 27, 2026 08:09 UTC
-
New hope for hard-to-treat lymphoma: experimental drug enters human testing
Disease control OngoingThe main purpose of this study is to characterize safety and to determine the recommended phase 2 dose (RP2D) for JNJ-88998377 (Part A: Dose Escalation), to further assess the safety of JNJ-88998377 at the RP2D (Part B: Dose Expansion).
Phase 1 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated Aug 30, 2026 00:00 UTC
-
Can antibodies keep HIV in check without daily pills?
Disease control CompletedThe main purpose of this study is to see if it is safe to give the study antibodies (3BNC117-LS-J and 10-1074-LS-J) by intravenous infusion to people with HIV (PWH), and to see if they cause any side effects. In addition, to see how the study antibodies affect the level of HIV in…
Phase 1 • Sponsor: Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections • Aim: Disease control
Last updated Aug 19, 2026 00:00 UTC
-
Spinal injection may prevent brain damage after aneurysm
Disease control Recruiting nowTo investigate whether patients with cerebral vasospasm associated with aneurysmal subarachnoid hemorrhage have a better prognosis with intrathecal nicardipine injection via extraventricular drainage or lumbar drainage.
Sponsor: The Affiliated Hospital Of Guizhou Medical University • Aim: Disease control
Last updated Jun 26, 2026 14:40 UTC
-
New nasal spray could replace needles for kids in pain
Symptom relief CompletedThe proposed study aims to investigate the safety, tolerability, analgesic efficacy, and feasibility of intranasal sufentanil/ketamine (CT001) in pediatric participants attending an acute care (i.e. emergency) setting. The study is a part of the clinical development plan for the …
Phase 2/3 • Sponsor: Cessatech A/S • Aim: Symptom relief
Last updated Jun 27, 2026 09:01 UTC
-
New shot shrinks skin cancer before surgery in early trial
Disease control OngoingThis is a multicenter, phase 2b, open-label, non-randomized, clinical trial to evaluate safety, tolerability, pharmacodynamics and preliminary efficacy of intra-lesional BO-112 in patients with resectable primary low and high risk basal cell carcinoma. * primary endpoint is visu…
Phase 2 • Sponsor: Highlight Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 08:14 UTC
-
Smart scan may help choose best breast cancer therapy
Knowledge-focused Recruiting nowEclectic is a strategy trial; once the class of treatment (endocrine therapy or chemotherapy) has been allocated according to 16α-18F-fluoro-17β-oestradiol (18F-FES) Positron Emission Tomography/Computed Tomography (PET/CT) results and circulating tumor biomarkers, clinicians wil…
Phase 3 • Sponsor: Institut Curie • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:09 UTC
-
New wireless sensor could let hydrocephalus patients monitor brain pressure at home
Disease control OngoingPatients with hydrocephalus have an abnormal build-up of fluid around the brain and need a tube surgically implanted to drain that fluid. Patients and their caregivers live with the constant fear that the tube will block. Warning symptoms include irritability, headaches and vomit…
Sponsor: University of Auckland, New Zealand • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
New pill could cut transfusions for thalassemia patients
Disease control Recruiting nowThis is a phase II, randomized, double-blinded, placebo-controlled study to treat patients with transfusion-dependent and non-transfusion dependent β -thalassemia with AND017 and optimal supportive care, including blood transfusion and iron removal, based on the clinician's judgm…
Phase 2 • Sponsor: Kind Pharmaceuticals LLC • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
Could a Balloon-Popping game boost brain health in older adults?
Symptom relief CompletedThe executive dysfunctions are a problem in individuals with MCI which predict conversion to dementia and is positively related to physical activity level. Previous studies found that exercise can prevent executive and physical dysfunctions for people with MCI. However, the motiv…
Sponsor: Mahidol University • Aim: Symptom relief
Last updated Jun 27, 2026 14:01 UTC
-
Can a magnetic helmet help stroke survivors heal faster?
Disease control CompletedThis is a multicenter, randomized, double-blind, sham-controlled, investigator-initiated clinical study, to evaluate the clinical efficacy and safety of LF-rTMS in rescuing the ischemic penumbra, reducing disability rate and improving functional outcome in patients with acute isc…
Sponsor: Beijing Tiantan Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC
-
Rhythmic cues boost walking after stroke: new trial tests combined training
Symptom relief Recruiting nowThe first objective of this study is to examine the superiority of the combined rhythmic auditory cueing with cognitive treadmill training (combined group) in people with stroke as compared with the cognitive treadmill walking training (cognitive group) or treadmill walking train…
Sponsor: Chang Gung University • Aim: Symptom relief
Last updated Jun 27, 2026 11:03 UTC
-
New Tri-Specific antibody takes on Hard-to-Treat myeloma
Disease control Recruiting nowThis is an open-label, multicenter phase 1 clinical trial to evaluate the safety and tolerability, efficacy, and pharmacokinetics of SIM0500 in adult participants with Relapsed or Refractory Multiple Myeloma(RRMM). The trial is consisted of two parts, Part 1 (dose escalation) and…
Phase 1 • Sponsor: Jiangsu Simcere Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Aug 30, 2026 00:00 UTC
-
Could regular MRIs replace invasive biopsies for prostate cancer monitoring?
Knowledge-focused Recruiting nowThe goal of this intervention study is for patients on active surveillance for prostate cancer, to demonstrate that use of regular MRI scans is better able to detect cancer progression over 5 years compared to the current NICE defined strategy. Research Question P - In patients …
Sponsor: Imperial College London • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:02 UTC
-
New asthma drug shows promise in cutting attacks
Disease control Stopped earlyThe primary objective of this study is to describe the efficacy of rocatinlimab in reducing asthma exacerbations.
Phase 2 • Sponsor: Amgen • Aim: Disease control
Last updated Aug 13, 2026 00:00 UTC
-
Can a ketogenic supplement boost brain health in older adults?
Disease control Recruiting nowEvaluation of the Effects of a Nutritional Intervention of Ketogenic Medium-chain Triglycerides and B-vitamins on Cognitive Functioning in Older Adults With Mild Cognitive Impairment (COGNIKET-MCI)
Sponsor: Société des Produits Nestlé (SPN) • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Can a gout drug protect kidneys and arteries?
Disease control CompletedThis study aimed to evaluate the impact of febuxostat on both carotid intima-media thickness and disease progression in individuals with chronic kidney disease
Phase 1 • Sponsor: Ain Shams University • Aim: Disease control
Last updated Jul 31, 2026 00:00 UTC
-
New antibody drug targets Hard-to-Treat cancers in early trial
Disease control Recruiting nowCDR404 is a highly potent and specific T-cell engaging bispecific and bivalent antibody designed for the treatment of cancers positive for the tumor-associated antigen melanoma-associated antigen 4 (MAGE-A4). This is a first-in-human study designed to evaluate the safety, tolerab…
Phase 1 • Sponsor: CDR-Life AG • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC